Gonadotrophin-releasing hormone antagonists for assisted conception - Wikidata - awgldk - TriplyDB

Gonadotrophin-releasing hormone antagonists for assisted conception

Gonadotrophin-releasing hormone antagonists for assisted conception

http://www.wikidata.org/entity/Q24245006

about

Optimal usage of the GnRH antagonists: a review of the literature Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.Estimating required information size by quantifying diversity in random-effects model meta-analyses.Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis Predictive factors for recovery time in patients suffering from severe OHSS.The Impact of Pituitary Blockage with GnRH Antagonist and Gonadotrophin Stimulation Length on The Outcome of ICSI Cycles in Women Older than 36 Years Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis.Prolonged gonadotropin stimulation is associated with decreased ART success.Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocol Assessment of the luteal phase in stimulated and substituted cycles.Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection Ovarian hyperstimulation syndrome.A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF.Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients The effects of GnRH antagonist on the endometrium of normally menstruating women.A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience.Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome Effect of overweight and obesity on assisted reproductive technology--a systematic review.GnRH analogues in the prevention of ovarian hyperstimulation syndrome Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes.Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study.Cessation of gonadotropin-releasing hormone antagonist on triggering day in flexible multiple-dose protocol: A randomized controlled study.Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders.Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes.Early pregnancy loss rates were different among singleton gestations conceived by ICSI using GnRH agonist and antagonist Approaches to improve the diagnosis and management of infertility Gonadotrophin releasing hormone antagonist in IVF/ICSI.Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro Restraint stress inhibits mouse implantation: temporal window and the involvement of HB-EGF, estrogen and progesterone.Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial.Observational Study to Assess the Therapeutic Value of Four Ovarian Hyperstimulation Protocols in IVF After Pituitary Suppression with GnRH Antagonists in Normally Responding Women.Increased Uterine NK cell numbers and perforin expression during the implantation phase in IVF Cycles with GnRH Antagonist Protocol.GnRH Antagonist IVF Protocol in PCOS.

P2860

Q21245566-CDCFB753-5DB0-400F-B58D-1B23238CBF54 Q24185849-FBAAE15B-7776-4217-BD28-4326AA2A3029 Q24234608-CC68BCFA-FFF5-4C2F-93A1-E3FB5334EDF4 Q24234909-F79BCE66-8E68-4447-81A1-AB859CBDA384 Q24240409-154FACBA-204F-4FDD-BE37-1A39496B004C Q28084432-FB9ACF25-844B-4896-9668-1C34DC1753B2 Q30399747-7EE74C99-ED2D-45CA-89BD-305A196FF43C Q33521365-8BB72468-2A1D-4111-AFD2-52A1CE0EBCAD Q33596777-B153CF21-4F69-4EAA-9A15-C33F1A002C86 Q33896594-A45D4A1E-6982-4EB2-91DB-9A2B4EA773B3 Q33937249-5D097DDD-7FF1-44BD-88DF-47173999FDAB Q34172380-1275E2B3-EB56-4D9F-A95C-70B6DEA3FA90 Q34384934-9DFB9714-3D0B-4ADC-8C35-EAAC907A4A18 Q34451981-2B1AAC90-7EE6-4A93-A241-0F389BB96A03 Q34607007-F88D5FF3-F8FF-4577-9F2B-BB9EF410777F Q34608208-91972C4C-A8D6-4F6F-A978-6D27CAB108EE Q35237847-11C239B4-8A6F-4813-8053-4AB49DC14E82 Q35493429-85ADEEDB-C468-4EA0-B24A-BF1D0453A2FD Q35804563-25E3DDCE-422E-4E24-A9B9-0910A21F8F63 Q36249259-67EF5F7E-0E8F-416A-8593-87AD84B0462B Q36268633-72557587-05C5-4156-BA06-E09A5199B1E4 Q36385538-FD1920E5-3768-4C9D-96B1-C17CC60E3D45 Q36542516-13CB4EC5-829A-4AA0-97AE-30C0F41E5640 Q36856192-4D74DF55-A84A-43FD-8F57-024A8209BE21 Q36957480-70F94B31-3087-48B8-A26C-FEFEB14F2BA3 Q36970080-A0BACD72-494D-44F2-82F6-E69475FEE3AE Q36970408-4670AB6F-B1A3-4D92-9ECD-1BD965701416 Q37022407-40A5C8B7-9106-4E42-A5E6-D999870EEBC8 Q37035301-25F1A02E-48F6-4F85-9926-3179B97BADAC Q37035354-9C758C50-0D37-491E-BEC2-9E1B8CA46AD1 Q37077680-E900CCEC-C96C-4B07-8024-DF3190E38759 Q37192437-AECCF3E5-D6C4-4C04-AEDA-9D847F6498A9 Q37214916-52A26179-049C-4987-BB51-F4E07DF282C7 Q37238190-D19CE383-20B5-4EB7-8E4A-7AB5D1BFEBDE Q37306594-D50CD41F-7664-422D-A747-0ADC60E8A4E5 Q37308948-877769AF-92E1-4BBB-9C68-196F82A4C1EF Q37350477-238AB082-CE76-4FD9-B38D-4BD2602D44BF Q37463040-BC8686E5-C482-4129-939F-282B5B73B752 Q37550317-691E015B-74AA-42B0-9A9C-77BF7C39A7E3 Q37622459-36AF425B-4EFE-449D-85DD-7FAA9CCB1456

P2860

Gonadotrophin-releasing hormone antagonists for assisted conception

http://www.wikidata.org/entity/Q24245006

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Gonadotrophin-releasing hormone antagonists for assisted conception

@ast

Gonadotrophin-releasing hormone antagonists for assisted conception

@en

Gonadotrophin-releasing hormone antagonists for assisted conception

@en-gb

Gonadotrophin-releasing hormone antagonists for assisted conception

@nl

type

label

Gonadotrophin-releasing hormone antagonists for assisted conception

@ast

Gonadotrophin-releasing hormone antagonists for assisted conception

@en

Gonadotrophin-releasing hormone antagonists for assisted conception

@en-gb

Gonadotrophin-releasing hormone antagonists for assisted conception

@nl

prefLabel

Gonadotrophin-releasing hormone antagonists for assisted conception

@ast

Gonadotrophin-releasing hormone antagonists for assisted conception

@en

Gonadotrophin-releasing hormone antagonists for assisted conception

@en-gb

Gonadotrophin-releasing hormone antagonists for assisted conception

@nl

P1433

Q24245006-A325C65A-C9D3-4D74-9C8D-607714F1E900

P1476

Q24245006-9C78585D-DC9E-4A06-8F03-0FAB85A3EF6E

P2093

Q24245006-4AEEAFC1-FD3D-4FF6-9752-420571E799F4

Q24245006-66513F89-F46E-4533-B8C2-B4C7A5AFAD3B

Q24245006-F52CBDEB-9EC0-4311-8966-85154E68E9C1

P2860

Q24245006-0392D07F-CBA2-490E-AA14-94CB8C0E249B

Q24245006-12EFC76A-B30A-45AF-9670-C25B63084496

Q24245006-256DB68F-772C-42BF-ABD4-EA2A8335C619

Q24245006-25A6096C-F09B-4A2E-A492-EB13A0E8FDED

Q24245006-340C893A-9E63-43F4-880A-D09B05CE7E2A

Q24245006-4721B3D5-A659-4D0A-88C7-F7D0F071B734

Q24245006-4FFE2BDF-ADCB-4699-B3BF-43B962B3BD33

Q24245006-50C1B2BC-1E06-4AA8-AB5F-943CAB149622

Q24245006-82E36B6C-6D81-48BB-98EF-1FB574CB3C82

Q24245006-9993971F-1D37-400B-8D8C-35732F009709

P31

Q24245006-1169174a-4b87-4114-ae2f-3c279782d3b7

Q24245006-BA139B72-83A9-40B2-92D7-722655054D8B

P3181

Q24245006-5668C0FE-C594-4979-8AC4-EDA9387C118D

P356

Q24245006-61BF38D0-152F-4CC2-B0A4-BA643942EE6D

P577

Q24245006-16DB1066-5280-40A1-8A45-E99B3535FA7B

P698

Q24245006-E8803F16-1606-478F-8239-D6AACE9C22CA

P3181

P356

14651858.CD001750.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Gonadotrophin-releasing hormone antagonists for assisted conception

@en

P2093

Ahmed M Abou-Setta

http://www.w3.org/2001/XMLSchema#string

Hesham G Al-Inany

http://www.w3.org/2001/XMLSchema#string

Mohamed Aboulghar

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.

Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.

Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study.

A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol.

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial.

A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study.

P31

scholarly article

P3181

4661740

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD001750.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16855976

http://www.w3.org/2001/XMLSchema#string